Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Andreia Tereso"'
Publikováno v:
Acta Médica Portuguesa, Vol 32, Iss 3, Pp 236-239 (2019)
The treatment of advanced non-small-cell lung cancer shifted with the development of molecular-targeted therapies, like the tyrosine kinase inhibitors. One example of tyrosine kinase inhibitors is crizotinib, an anaplastic lymphoma tyrosine kinase in
Externí odkaz:
https://doaj.org/article/de577c15a45146e58d2933ffdb7452a7
Publikováno v:
International Journal of Medical Science and Clinical invention. 6:4608-4611
Solitary fibrous tumors were initially described in the pleural cavity and they were thought to have mesothelial origin. Nowadays, these tumors are known to have origin in the mesenchymal cells and they are ubiquitous with both pleural and extrapleur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6d61a512c99964abd3056ac4ea4085d
https://doi.org/10.18535/ijmsci/v6i10.01
https://doi.org/10.18535/ijmsci/v6i10.01
Publikováno v:
Radiologia Brasileira v.53 n.5 2020
Radiologia Brasileira
Colégio Brasileiro de Radiologia e Diagnóstico por Imagem (CBR)
instacron:CBR
Radiologia Brasileira, Volume: 53, Issue: 5, Pages: 349-355, Published: 02 OCT 2020
Radiologia Brasileira
Colégio Brasileiro de Radiologia e Diagnóstico por Imagem (CBR)
instacron:CBR
Radiologia Brasileira, Volume: 53, Issue: 5, Pages: 349-355, Published: 02 OCT 2020
Although secondary involvement of the broad ligament by malignant tumors arising elsewhere in the abdomen and pelvis is common, primary tumors in this location are rare. Tumors of the broad ligament can be of mesenchymal and mixed nature, such as lei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edd5cf92ad4eb3a3234a11e5fa349be3
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-39842020000500013
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-39842020000500013
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Acta Médica Portuguesa, Vol 32, Iss 3, Pp 236-239 (2019)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Acta Médica Portuguesa, Vol 32, Iss 3, Pp 236-239 (2019)
The treatment of advanced non-small-cell lung cancer shifted with the development of molecular-targeted therapies, like the tyrosine kinase inhibitors. One example of tyrosine kinase inhibitors is crizotinib, an anaplastic lymphoma tyrosine kinase in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e79f87d0af9723469bdc3f29a45835e
Publikováno v:
Acta Médica Portuguesa; Mar2019, Vol. 32 Issue 3, p236-239, 4p